| No Mortality (N = 154) | Mortality (N = 11) | P value |
---|---|---|---|
Male | 76 (49.4%) | 6 (54.5%) | Â |
Age (years) | 31.2 (29.3–33.0) | 48.7 (43.0–54.4) |  < 0.001 |
LVEDVI (ml/m2) | 66.1 (62.8–69.3) | 82.0 (71.7–92.3) | 0.003 |
LVESVI (ml/m2) | 26.6 (24.4–28.8) | 40.0 (31.8–48.3) | 0.001 |
LVEF (%) | 60.7 (59.1–62.3) | 51.9 (45.2–58.5) | 0.009 |
RVEDVI (ml/m2) | 122.7 (115.7–129.6) | 142.3 (106.1–178.5) | 0.371 |
RVESVI (ml/m2) | 65.3 (60.2–70.4) | 78.3 (46.9–109.6) | 0.682 |
RVEF (%) | 48.0 (46.3–49.7) | 48.5 (42.9–54.1) | 0.746 |
LA volume and function by mortality in rTOF (restricted to subjects with LA volume) | |||
 Indexed LAmax Vol. (ml/m2) | 29.5 (27.6–31.4) | 45.9 (35.0–56.7) |  < 0.001 |
 Indexed LAmin Vol. (ml/m2) | 14.5 (13.0–16.0) | 26.5 (19.4–33.5) |  < 0.001 |
 Indexed LA BAC Vol. (ml/m2) | 21.7 (19.9–23.4) | 37.2 (29.1–45.3) |  < 0.001 |
 Total LA Fxn (%) | 51.7 (49.7–53.7) | 43.4 (36.9–50.0) | 0.029 |
 Passive LA Fxn (%) | 27.2 (25.4–29.1) | 18.5 (13.4–23.5) | 0.012 |
 Active LA Fxn (%) | 63.0 (61.5–64.4) | 62.9 (56.4–69.3) | 0.931 |
LV diastology | |||
 PER (ml/s) | 310 (295–325) | 321 (259–382) | 0.746 |
 tPER (ms) | 136 (130–143) | 148 (121–175) | 0.426 |
 PER/EDV (s−1) | 3.76 (2.06–5.47) | 2.10 (1.93–2.28) |  < 0.001 |
 PFR (ml/s) | 297 (280–314) | 296 (220–373) | 0.830 |
 tPFR (ms) | 141 (134–149) | 207 (146–267) | 0.018 |
 PFR/EDV (s−1) | 2.74 (2.62–2.86) | 1.94 (1.58–2.30) | 0.001 |